Orforglipron had a similar safety profile as other GLP-1 receptor agonists. Trial outcomes For ATTAIN-2, researchers enrolled 1,613 adults aged 18 years and older with obesity or overweight plus one weight-related comorbidity, and with type 2 diabetes with an HbA1c between 7% and 10% at baseline (mean age, 56.8 years
Non-12-OH FXR-antagonistic BAs mediates the T3 effect on glucose homeostasis To dissect the contribution of the augmentation of non-12-OH FXR-antagonistic BAs to the improved glucose metabolism after T3 daily injection, MMI mice were fed a diet supplemented with TMCA, the most abundant murine FXR-antagonistic BA, for five days
Histochem Histochem Histochim (1966) 7:197201
Studies** have shown that even in successful diets more than half of the weight lost is regained within two years, and by five years, over 80% of lost weight is regained
Lung cancer: epidemiology, etiology, and prevention